Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Polyneuropathies

• Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN
• Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
• Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy
• Daratumumab for Polyneuropathy Associated With MGUS
• A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy
• Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt
• A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.
• IVIG vs SCIG in CIDP
• To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
• Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China
• A Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
• Spectrum of Peripheral and Autonomic Neuropathies in Patients With wtATTR Amyloidosis and Response to Patisiran Therapy"
• A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV
• The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients
• Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
• Efficacy and Safety of Acoramidis (AG10) in Subjects With Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)
• The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
• Proof-of-concept Study for BIVV020 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy
• Phenytoin Cream for the Treatment of Neuropathic Pain
• Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
• Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy
• Alpha Lipoic Acid and Diabetes Mellitus: Potential Effects on Peripheral Neuropathy
• To Assess the Bioequivalence of Test Oral Formulation of Alpha Lipoic Acid 600 mg HR Film Coated Tablets of Ilko Ilac San. Ve Tic. A.S. Versus Reference Thioctacid (Alpha Lipoic Acid) 600 mg HR Film Coated Tablets of Meda Pharma GmbH& CO .KG, German
• IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS or FGFR-3 Antibodies
• NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
• Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy
• Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Panzyga in CIDP Administered at Different Infusion Rates
• Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy
• Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients
• SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
• Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
• Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer
• Comparison of the Efficacy of the Ultrasound With Fluoroscopy in Guidance of Lumbar Sympathetic Block
• Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain
• The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant
• Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
• The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)
• Subcutaneous Immunoglobulin for CIDP
• IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
• IVIg for Demyelination in Diabetes Mellitus
• Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
• Study of SOM0226 in Familial Amyloid Polyneuropathy
• Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)
• Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy
• Immunoglobulin Dosage and Administration Form in CIDP and MMN
• A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy
• APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis
• The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
• Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
• Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
• Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
• A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
• The Effect of Rosuvastatin in Diabetic Polyneuropathy: A Phase IIa Randomized Double-blind Placebo-controlled Study
• Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy
• The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin
• Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg
• Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy
• Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
• Neuropathic Pain Management
• Botulinum Toxin in Peripheral Neuropathic Pain
• High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
• Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy
• Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin
• Efficacy of Etoricoxib on Peripheral Hyperalgesia
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
• Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
• A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)
• Imipramine and Pregabalin Combination in Painful Polyneuropathy
• Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy
• Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
• Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
• A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diab
• Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy
• Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
• Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy
• An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
• Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
• Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
• Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509
• The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
• Neuropathic Pain Syndrome Patient Study (MK-0000-072)
• ASP 8825 - Study in Patients With Painful Diabetic Polyneuropathy
• Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
• Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
• Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)
• Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
• Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)
• Safety and Efficacy of MCC-257 in the Treatment of Diabetic Polyneuropathy
• The Effect of Diflunisal on Familial Amyloidosis
• Levetiracetam for Painful Polyneuropathy
• Effect of C-Peptide on Diabetic Peripheral Neuropathy
• RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy
• A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy
• ALCAR Prophylaxis Study
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
• Escitalopram as a Treatment for Pain in Polyneuropathy
• A Study to Determine if Levetiracetam Will Assist Those Suffering From Chronic Idiopathic Axonal Polyneuropathy.
• Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy
• An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
• Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain
• Rituximab to Treat Neuropathy With Anti-MAG Antibodies
• Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy
• Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)